Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

This page is alzhub.org's plain-English summary of a published study, not the paper itself. It is generated from the record we hold for this study, sourced and linked below — check the original for the full text and methods.

✓ Peer-reviewed alzhub usefulness score 44 out of 100. Inflammation and the immune system

Topic: Amyloid, tau and blood-test diagnosis

Plain-language summary

The potential role of aluminum (Al) in the onset and progression of Alzheimer disease (AD) remains among the most enduring and divisive controversies in environmental neurotoxicology. Although numerous narrative reviews, systematic reviews, meta-analyses, mechanistic appraisals, and toxicological assessments have been published, their conclusions remain heterogeneous and at times contradictory. The present review of reviews critically integrates the PubMed-indexed review literature published in this century (January 1, 2000, and May 2, 2026), focusing on epidemiology, exposure sources, toxicokinetics, biological plausibility, experimental models, biomarkers, preventive measures, and unresolved methodological challenges. A predefined selection strategy was applied, prioritizing reviews that directly addressed Al and AD, employed systematic or meta-analytic approaches, examined epidemiological or mechanistic evidence, evaluated exposure assessment, or offered influential conceptual frameworks. Peripheral reviews were considered only when they provided essential context. The methodological quality of the included reviews was appraised qualitatively, considering transparency of the search strategy, reproducibility of methods, consideration of bias, and relevance to the review objectives. The strength of the evidence supporting each main conclusion was graded as strong, moderate, or limited. The evidence reviewed indicates that Al can promote several AD-related biological processes in experimental settings, including oxidative stress, mitochondrial dysfunction, neuroinflammation, glial activation, disrupted calcium signaling, amyloid beta aggregation, impaired amyloid clearance, tau phosphorylation, autophagy impairment, and epigenetic alterations. Epidemiological findings are less consistent, although several meta-analyses link chronic, occupational, or drinking-water Al exposure with cognitive decline and AD risk, despite limitations from exposure misclassification, confounding, and methodological heterogeneity. Overall, the evidence neither identifies Al as the principal cause of AD nor dismisses its relevance, supporting instead a contributory role within a multifactorial disease model, especially in susceptible individuals.

What this study adds

Evidence grade: High

This is a pooled review. This review of reviews weighed evidence on aluminum and Alzheimer's published since 2000. Lab studies show aluminum can promote several Alzheimer-related processes such as oxidative stress, amyloid beta aggregation and tau phosphorylation, while population studies are less consistent, though some link long-term or drinking-water exposure to higher risk.

Taken from this record’s own fields, not from reading the paper. The grade is assigned from the abstract’s wording; what that means.

Cite this study APA, Vancouver, BibTeX · download .bib or .ris

APA 7th

Domingo, J. L., & Colomina, M. T. (2026). Aluminum and Alzheimer's disease in the 21st century: An umbrella review of evidence and controversies. Neurotoxicology. https://doi.org/10.1016/j.neuro.2026.103531

Vancouver

Domingo JL, Colomina MT. Aluminum and Alzheimer's disease in the 21st century: An umbrella review of evidence and controversies. Neurotoxicology. 2026. doi:10.1016/j.neuro.2026.103531. PMID: 42497677.

BibTeX

@article{domingo2026-42497677,
  author  = {Domingo, J. L. and Colomina, M. T.},
  title   = {{Aluminum and Alzheimer's disease in the 21st century: An umbrella review of evidence and controversies}},
  journal = {Neurotoxicology},
  year    = {2026},
  doi     = {10.1016/j.neuro.2026.103531},
  pmid    = {42497677},
  url     = {https://doi.org/10.1016/j.neuro.2026.103531}
}

Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. Check the citation against the original before you use it.

Key findings

Why it matters

This review of reviews weighed evidence on aluminum and Alzheimer's published since 2000. Lab studies show aluminum can promote several Alzheimer-related processes such as oxidative stress, amyloid beta aggregation and tau phosphorylation, while population studies are less consistent, though some link long-term or drinking-water exposure to higher risk. The authors conclude aluminum is neither the main cause of Alzheimer's nor irrelevant, but possibly a contributing factor, especially in susceptible people.

Study details

How this study scored 44/100
How this study's score is builtJournal tier 7 of 10; Journal's citation record 1 of 4; Study design 12 of 12; Strength of evidence 5 of 5; Peer-review validation 10 of 10; How recent 5 of 5; Sample size 0 of 4; Effect reported 0 of 3; Studied in people 0 of 3; Randomized / blinded 0 of 2; Times cited 0 of 7; Citations per year 0 of 5; Impact for its field and year 0 of 6; Cited by studies here 0 of 6; Still being cited 0 of 4; Senior author's track record 2 of 4; Institution's track record 0 of 3; Multicenter collaboration 0 of 3; Indexed in PubMed 2 of 2; Free to read 0 of 2. Total 44 of 100.44 of 100 points earned56 not earned

Published in a peer-reviewed journal, and it is a meta-analysis pooling many studies. Scored zero for sample size, effect reported and studied in people because the record does not state it.

ComponentPointsWhy
Journal tier 7 / 10 Tier 3 — peer-reviewed journal (Neurotoxicology)
Journal's citation record 1 / 4 NeuroToxicology: journal h-index 142 (OpenAlex, 2026-10-29)
Study design 12 / 12 A meta-analysis pooling many studies
Strength of evidence 5 / 5 Rated “high” in our summary
Peer-review validation 10 / 10 Peer-reviewed. Published as an article in a named peer-reviewed journal.
How recent 5 / 5 2026 — within 1 year(s) of the newest study here
Sample size 0 / 4 Participant count not stated — scores zero (not stated in the record — scored 0)
Effect reported 0 / 3 No effect size reported — scores zero (not stated in the record — scored 0)
Studied in people 0 / 3 Not stated whether this was studied in people — scores zero (not stated in the record — scored 0)
Randomized / blinded 0 / 2 A review of other studies — randomization is not credited here
Times cited 0 / 7 Cited 0 times (OpenAlex, 2026-10-10)
Citations per year 0 / 5 0.0 citations a year over 2 year(s) since 2026
Impact for its field and year 0 / 6 Cited 0.0× the average for papers of its field and year (OpenAlex FWCI)
Cited by studies here 0 / 6 No other study in this library cites it
Still being cited 0 / 4 Cited 0 times in 2024–2026 (2026 still in progress; OpenAlex)
Senior author's track record 2 / 4 Last-listed author María Teresa Colomina: h-index 36 (OpenAlex, whole career)
Institution's track record 0 / 3 Universitat Rovira i Virgili: institution h-index 444 (OpenAlex)
Multicenter collaboration 0 / 3 OpenAlex lists 1 institution(s) in 1 country — scores zero (affiliation lists can be incomplete)
Indexed in PubMed 2 / 2 Indexed in PubMed (PMID 42497677)
Free to read 0 / 2 Behind a paywall — scores zero
Total 44 / 100 —

What each of these 20 components measures, and what this score is not →

Read the original

Full text: free to read — OpenAlex lists this copy as free to read: the link above (checked 6 Feb 1020).

Studies in the library that share something with this one. The line above each title says what.

Studies this one cites

Referenced by this study and also in the alzhub library, so you can read them here.

Related studies in Inflammation and the immune system from nearby years

Also in Inflammation and the immune system

141 studies in the library are filed under Inflammation and the immune system with no topic tag they share with another; these are this study's neighbours in a fixed tour of them. The Inflammation and the immune system hub.

Similar studies

More on Inflammation and the immune system

See all studies in Inflammation and the immune system →